Application 218061
- Type
- ANDA
- Sponsor
- XIROMED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CETRORELIX ACETATE | CETRORELIX ACETATE | POWDER;SUBCUTANEOUS | EQ 0.25MG BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218061-001 | CETRORELIX ACETATE | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER / SUBCUTANEOUS | AP | 2025-06-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218061-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218061-001 | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER / SUBCUTANEOUS | AP | 2025-06-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218061-001 | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER / SUBCUTANEOUS | AP | 2025-06-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218061-001 | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER / SUBCUTANEOUS | AP | 2025-06-03 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218061-001 | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER / SUBCUTANEOUS | AP | 2025-06-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218061-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218061-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218061-001 | AP | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218061-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetrotide | CETRORELIX ACETATE | EMD Serono, Inc. | aca7768e-28a7-4027-b1d8-e66247665f79 | 2025-09-22 | Warnings, Adverse reactions | CETRORELIX ACETATE |
| Cetrorelix acetate | CETRORELIX ACETATE FOR INJECTION | Apotex Corp. | 95b852d6-26a4-4aaf-a4c3-26340a24723d | 2025-06-12 | Warnings, Adverse reactions | Cetrorelix acetate |
| Cetrorelix Acetate | CETRORELIX ACETATE | Meitheal Pharmaceuticals Inc. | 9b3057ac-6cac-4509-a355-df76247b992c | 2024-09-10 | Warnings, Adverse reactions | Cetrorelix Acetate CETRORELIX ACETATE |
| cetrorelix acetate | CETRORELIX ACETATE | Gland Pharma Limited | 89f8f8ee-68ac-4ed0-a7e3-ffd6e0c1290a | 2024-08-08 | Warnings, Adverse reactions | cetrorelix acetate CETRORELIX ACETATE |
| cetrorelix acetate | CETRORELIX ACETATE | FRESENIUS KABI USA, LLC | c9c50fcb-b28d-4085-9116-b38a21d31b99 | 2024-07-12 | Warnings, Adverse reactions | cetrorelix acetate CETRORELIX ACETATE |
| Cetrorelix acetate | CETRORELIX ACETATE FOR INJECTION | Qilu Pharmaceutical Co., Ltd. | c1f35ca4-3536-44ca-ad0e-02f484019456 | 2024-04-18 | Warnings, Adverse reactions | Cetrorelix acetate |